Previous 10 | Next 10 |
Gainers: Lianluo Smart (LLIT) +30%, Galera Therapeutics (GRTX) +18%, Selecta Biosciences (SELB) +16%, Mirati Therapeutics (MRTX) +14%, GeoVax Labs (GOVX) +14%.Losers: BioSig Technologies (BSGM) -40%, Aileron Therapeutics (ALRN) ...
Interim data from first 19 patients in Phase 1/2 trial evaluating Galera Therapeutics' (GRTX) lead candidate avasopasem manganese (GC4419) in combination with stereotactic body radiation therapy ((SBRT)), showed improvement in overall survival ((OS)) and multiple anti-cancer ef...
Interim d ata on first 19 patients released in ASTRO Annual Meeting late-breaker presentation abstract showed improvement in overall survival and multiple anti-cancer efficacy measures Interim data from full patient population to be presented ...
Galera Therapeutics ([[GRTX]] +2.4%) has dosed the first patient has in Phase 1/2 GRECO-1 trial of GC4711 in combination with stereotactic body radiation therapy ((SBRT)) in patients with non-small cell lung cancer ((NSCLC)).The trial is supported in part by a recently awarded Small Business&...
MALVERN, Pa., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today ann...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
MALVERN, Pa., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today an...
Galera Therapeutics (NASDAQ: GRTX ) has dosed the first patient in a Phase 2 trial of lead candidate avasopasem manganese (GC4419) in critically ill hospitalized COVID-19 patients. More news on: Galera Therapeutics, Inc., Healthcare stocks news, Read more ...
Trial to enroll up to 50 hospitalized adults critically ill with COVID-19 Company continues to advance its three ongoing trials evaluating the potential of GC4419 to address radiation toxicities and improve the anti-cancer effect of radiation MALVERN, Pa., Sept. 16, 2020 (GLOBE NEW...
MALVERN, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today an...
News, Short Squeeze, Breakout and More Instantly...
Galera Therapeutics Inc. Company Name:
GRTX Stock Symbol:
NYSE Market:
Galera Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...
A look at the top 10 most actives in the United States ENDRA Life Sciences Inc. (NDRA) rose 88.2% to $0.159999 on volume of 216,555,450 shares Crown Electrokinetics Corp. (CRKN) fell 13.1% to $0.0908 on volume of 52,298,971 shares Actelis Networks Inc (ASNS) rose 591.5% to $3.25 on volume...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...